Differentiating In Logistics For Regenerative Medicine’s Exploding Universe
Cryoport is a unique company in its niche – supporting regenerative medicine clinical trials and commercial products with cold chain logistics – and has designs on becoming a full supply chain partner for the biopharma industry. CEO Jerry Shelton explained the company’s current role and future plans to In Vivo during the recent Jefferies Healthcare conference.
You may also be interested in...
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.